查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602706

苯磺酸氨氯地平市场：按类型、应用分类 - 全球预测 2025-2030

Amlodipine Besylate Market by Type (10 mg Tablets, 2.5 mg Tablets, 5 mg Tablets), Application (Heart Diseases, High Blood Pressure) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年苯磺酸氨氯地平市值为41337万美元，预计2024年将达到43728万美元，复合年增长率为6.18%，预计2030年将达到62905万美元。

苯磺酸氨氯地平是一种钙拮抗剂，广泛用于治疗高血压和冠状动脉疾病。对苯磺酸氨氯地平的需求是因为它能有效控制这些疾病并降低心臟病发作、中风和肾臟损伤的风险。苯磺酸氨氯地平主要用于製药领域，最终用途包括医院药局、零售药局和网路药局。苯磺酸氨氯地平市场受到心血管疾病盛行率上升、人口老化以及预防保健意识增强的影响。特别是在发展中地区，由于医疗基础设施的改善和药品取得范围的扩大，这一趋势正在加速。主要商机在于由于成本优势和品牌药专利到期对学名药药苯磺酸氨氯地平的需求增加。市场相关人员可能会透过加强分销网络和开拓新兴市场（特别是亚太地区和拉丁美洲）而受益。挑战包括严格的监管政策、潜在的副作用以及来自替代疗法和文明病治疗的竞争。此外，学名药市场的饱和对盈利构成威胁。药物传递的创新可以集中在改进缓释性、同时针对多种疾病的联合治疗，并透过经皮贴片和奈米颗粒等新的药物传递系统来提高患者的依从性。对个人化医疗方法的研究也可能提供差异化产品并占领利基市场。儘管市场本质上竞争激烈，众多学名药压低了价格，但公司仍有机会利用技术进步和战略伙伴关係关係来开拓开拓的市场。总体而言，虽然市场格局面临挑战，但透过策略创新和适应不断变化的医疗保健格局，存在巨大的成长机会。

主要市场统计
基准年[2023] 41337万美元
预测年份 [2024] 43728万美元
预测年份 [2030] 62905万美元
复合年增长率（%） 6.18%

市场动态：快速发展的苯磺酸氨氯地平市场的关键市场洞察

苯磺酸氨氯地平市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 高血压和心臟病盛行率上升
    • 苯磺酸氨氯地平在各种治疗的使用增加
    • 冠状动脉疾病治疗指引的执行
  • 市场限制因素
    • 氨氯地平替代品的可用性
  • 市场机会
    • 更多采用快速检测和照护现场诊断
    • 加大氨氯地平研发投入
  • 市场挑战
    • 对苯磺酸氨氯地平副作用的担忧

波特的五力：驾驭苯磺酸氨氯地平市场的策略工具

波特的五力架构是了解苯磺酸氨氯地平市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解苯磺酸氨氯地平市场的外部影响

外部宏观环境因素在塑造苯磺酸氨氯地平市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解苯磺酸氨氯地平市场的竞争格局

对苯磺酸氨氯地平市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 苯磺酸氨氯地平市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估苯磺酸氨氯地平市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製苯磺酸氨氯地平市场的成功之路

苯磺酸氨氯地平市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 高血压和心臟病的发生率增加
      • 苯磺酸氨氯地平在各种治疗的使用增加
      • 冠心病治疗指出的实施
    • 抑制因素
      • 氨氯地平替代品的可用性
    • 机会
      • 快速检测的兴起和照护现场诊断的引入
      • 增加对苯磺酸氨氯地平研发活动的投资
    • 任务
      • 关于苯磺酸氨氯地平副作用的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章苯磺酸氨氯地平市场：依类型

  • 10毫克片剂
  • 2.5毫克片剂
  • 5毫克片剂

第七章苯磺酸氨氯地平市场：依应用分类

  • 心臟病
  • 高血压

第八章 苯磺酸氨氯地平北美、南美市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区苯磺酸氨氯地平市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲苯磺酸氨氯地平市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cadila Pharmaceuticals Limited
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co., Ltd.
  • Chartwell Pharmaceuticals LLC
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • Lupin Limited
  • MOEHS IBERICA, SL
  • Orbion Pharmaceuticals Private Limited
  • Pfizer Inc.
  • Sanofi SA
  • Strides Pharma Science Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-742BD517AAF1

The Amlodipine Besylate Market was valued at USD 413.37 million in 2023, expected to reach USD 437.28 million in 2024, and is projected to grow at a CAGR of 6.18%, to USD 629.05 million by 2030.

Amlodipine Besylate, a calcium channel blocker, is extensively used for treating hypertension and coronary artery disease. The necessity of Amlodipine Besylate stems from its efficacy in managing these conditions, reducing the risk of heart attacks, strokes, and kidney problems. It's primarily applied in the pharmaceutical sector, with end-use spanning hospital pharmacies, retail pharmacies, and online pharmacies. The market for Amlodipine Besylate is influenced by the rising prevalence of cardiovascular diseases, an aging population, and increasing awareness around preventative healthcare. Notably, there is a growing trend in developing regions due to improved healthcare infrastructure and expanding access to medications. A key opportunity lies in the increasing demand for generic versions of Amlodipine Besylate, driven by cost advantages and patent expirations of branded drugs. Market players could benefit by enhancing distribution networks and tapping into emerging markets, particularly in Asia-Pacific and Latin America. Challenges include stringent regulatory policies, potential side effects, and competition from alternative therapies and lifestyle interventions. Additionally, generic market saturation poses a threat to profitability. Innovations could focus on improving the drug's formulation for sustained release, combination therapies to target multiple ailments concurrently, and enhancing patient compliance through novel drug delivery systems like transdermal patches or nanoparticles. Research into personalized medicine approaches could also offer differentiated products, capturing niche market segments. The market is inherently competitive, with numerous generics driving down prices, but opportunities exist for companies that can leverage technological advancements and strategic partnerships to enter underserved markets. Overall, while the Amlodipine Besylate market faces challenges, there are substantial opportunities for growth through strategic innovation and adaptation to the evolving healthcare landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 413.37 million
Estimated Year [2024] USD 437.28 million
Forecast Year [2030] USD 629.05 million
CAGR (%) 6.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Amlodipine Besylate Market

The Amlodipine Besylate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of hypertension and heart diseases
    • Increasing usage of amlodipine besylate in various treatments
    • Implementation of guidelines for coronary artery disease treatment
  • Market Restraints
    • Availability of alternative medications to amlodipine
  • Market Opportunities
    • Emerging adoption of rapid testing and point-of-care diagnosis
    • Increasing investments in research and development activities of amlodipine besylate
  • Market Challenges
    • Concerns associated with side effects of amlodipine besylate

Porter's Five Forces: A Strategic Tool for Navigating the Amlodipine Besylate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Amlodipine Besylate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Amlodipine Besylate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Amlodipine Besylate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Amlodipine Besylate Market

A detailed market share analysis in the Amlodipine Besylate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Amlodipine Besylate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Amlodipine Besylate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Amlodipine Besylate Market

A strategic analysis of the Amlodipine Besylate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Amlodipine Besylate Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Aurobindo Pharma Limited, Cadila Pharmaceuticals Limited, Century Pharmaceuticals Ltd., Changzhou Yabang Pharmaceutical Co., Ltd., Chartwell Pharmaceuticals LLC, Cipla Inc., Dr. Reddys Laboratories Ltd., Lupin Limited, MOEHS IBERICA, SL, Orbion Pharmaceuticals Private Limited, Pfizer Inc., Sanofi S.A., Strides Pharma Science Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Amlodipine Besylate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across 10 mg Tablets, 2.5 mg Tablets, and 5 mg Tablets.
  • Based on Application, market is studied across Heart Diseases and High Blood Pressure.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of hypertension and heart diseases
      • 5.1.1.2. Increasing usage of amlodipine besylate in various treatments
      • 5.1.1.3. Implementation of guidelines for coronary artery disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative medications to amlodipine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging adoption of rapid testing and point-of-care diagnosis
      • 5.1.3.2. Increasing investments in research and development activities of amlodipine besylate
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with side effects of amlodipine besylate
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Amlodipine Besylate Market, by Type

  • 6.1. Introduction
  • 6.2. 10 mg Tablets
  • 6.3. 2.5 mg Tablets
  • 6.4. 5 mg Tablets

7. Amlodipine Besylate Market, by Application

  • 7.1. Introduction
  • 7.2. Heart Diseases
  • 7.3. High Blood Pressure

8. Americas Amlodipine Besylate Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Amlodipine Besylate Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Amlodipine Besylate Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apotex Inc.
  • 2. Aurobindo Pharma Limited
  • 3. Cadila Pharmaceuticals Limited
  • 4. Century Pharmaceuticals Ltd.
  • 5. Changzhou Yabang Pharmaceutical Co., Ltd.
  • 6. Chartwell Pharmaceuticals LLC
  • 7. Cipla Inc.
  • 8. Dr. Reddys Laboratories Ltd.
  • 9. Lupin Limited
  • 10. MOEHS IBERICA, SL
  • 11. Orbion Pharmaceuticals Private Limited
  • 12. Pfizer Inc.
  • 13. Sanofi S.A.
  • 14. Strides Pharma Science Limited
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. AMLODIPINE BESYLATE MARKET RESEARCH PROCESS
  • FIGURE 2. AMLODIPINE BESYLATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AMLODIPINE BESYLATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AMLODIPINE BESYLATE MARKET DYNAMICS
  • TABLE 7. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY 10 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY 2.5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY 5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023